semaglutide mash fda approval Diabetes Dialogue: Approves (Wegovy) for Wegovy FDA Approval for MASH

Accumulating evidence supports a more complex model in which obesity contributes to KOA through both biomechanical and systemic mechanisms

July 1, 2019

Chemotherapy-Induced Neuropathy CAUTION Hershman et al

The day before, her agent told her he'd been "meaning to talk to" her about her body, and he discussed her figure as if he was talking about a car

GLP-1 therapy doesnt affect ability to handle service or K-9 animals

Fr Schwangerschaft und Stillzeit gilt wie bei vielen kosmetischen Wirkstoffen: Auch wenn topisch angewendete Kupferpeptide nicht als stark problematisch gelten, ist es sinnvoll, neue aktive Wirkstoffe in dieser Zeit im Zweifel vorher medizinisch abzuklren